Pacira BioSciences, Inc. (PCRX)
| Previous Close | 16.78 |
| Open | 16.80 |
| Bid | 16.66 x 200 |
| Ask | 16.80 x 100 |
| Day's Range | 16.58 - 16.99 |
| 52 Week Range | 11.16 - 35.95 |
| Volume | |
| Avg. Volume | 781,201 |
| Market Cap | 772.016M |
| Beta (5Y Monthly) | 0.82 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.98 |
| Earnings Date | Feb 26, 2025 - Mar 03, 2025 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 18.00 |
GlobeNewswirePacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee
-- Poster to be presented at ACR Convergence annual meeting --PARSIPPANY, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced new data demonstrating its gene therapy for osteoarthritis candidate, PCRX-201 (enekinragene inzadenovec), provided sustained improvements in knee pain, stiffness, and function to 104 weeks following local administra
- GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the following two healthcare conferences: Jefferies London Healthcare Conference on Tuesday, November 19th at 3:00PM GMT (10:00AM ET).36th Annual Piper Sandler Healthcare Conference on Tuesday, December 3rd at 1:00PM ET. Live audio of the events can be accessed by visiting the “Events” page of the company’s website at investor.pac
